Lenvatinib plus pembrolizumab for patients with previously treated, advanced, triple-negative breast cancer: Results from the triple-negative breast cancer cohort of the phase 2 LEAP-005 Study.

Autor: Chung HC; Department of Medical Oncology, Yonsei Cancer Center, Yonsei Song-Dang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea., Saada-Bouzid E; Department of Medical Oncology, Cote d'Azur University, Centre Antoine Lacassagne, Nice, France., Longo F; Medical Oncology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria, Centro de Investigación Biomédica en Red Cáncer, Alcalá University, Madrid, Spain., Yanez E; Oncology-Hematology Unit, University of Frontera, Araucanía, Chile., Im SA; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea., Castanon E; Department of Oncology, Clínica Universidad de Navarra, Madrid, Spain., Desautels DN; Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada., Graham DM; Experimental Cancer Medicine Team, The Christie National Health Service Foundation Trust, Manchester, UK.; University of Manchester, Manchester, UK., Garcia-Corbacho J; Clinical Institute of Hemato-Oncological Diseases, Hospital Clinic, Barcelona, Spain., Lopez J; Phase I Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, UK., Dutcus C; Eisai Inc., Nutley, New Jersey, USA., Okpara CE; Eisai Ltd., Hatfield, UK., Ghori R; Merck & Co., Inc., Rahway, New Jersey, USA., Jin F; Merck & Co., Inc., Rahway, New Jersey, USA., Groisberg R; Merck & Co., Inc., Rahway, New Jersey, USA., Korakis I; Department of Medicine and Clinical Research Unit, Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse (IUCT-Oncopole), Toulouse, France.

Publikováno v: Cancer [Cancer] 2024 Oct 01; Vol. 130 (19), pp. 3278-3288. Date of Electronic Publication: 2024 Jun 21.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Parotiditis crónica recurrente juvenil

Autor: Concheiro Guisán, A., Bellver Castañón, E., Garrido Romero, R., García-Tornel Florensa, S.

Publikováno v: In Anales de Pediatria 2000 53(5):418-421

Intratumoural administration and tumour tissue targeting of cancer immunotherapies.

Autor: Melero I; Department of Immunology, Clínica Universidad de Navarra, Pamplona, Spain. imelero@unav.es.; Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain. imelero@unav.es.; Program for Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Universidad de Navarra, Pamplona, Spain. imelero@unav.es.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain. imelero@unav.es.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. imelero@unav.es., Castanon E; Department of Immunology, Clínica Universidad de Navarra, Pamplona, Spain.; Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain., Alvarez M; Program for Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Champiat S; Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Université Paris Saclay, Gustave Roussy, Villejuif, France.; INSERM U1015, Gustave Roussy, Villejuif, France.; Biotherapies for In Situ Antitumor Immunization (BIOTHERIS), Centre d'Investigation Clinique INSERM CICBT1428, Villejuif, France., Marabelle A; Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Université Paris Saclay, Gustave Roussy, Villejuif, France. aurelien.marabelle@gustaveroussy.fr.; INSERM U1015, Gustave Roussy, Villejuif, France. aurelien.marabelle@gustaveroussy.fr.; Biotherapies for In Situ Antitumor Immunization (BIOTHERIS), Centre d'Investigation Clinique INSERM CICBT1428, Villejuif, France. aurelien.marabelle@gustaveroussy.fr.

Publikováno v: Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2021 Sep; Vol. 18 (9), pp. 558-576. Date of Electronic Publication: 2021 May 18.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.